アストラ製を途上国提供　ワクチン不足支援―政府検討

　政府は、供給契約を結んでいる英製薬大手アストラゼネカの新型コロナウイルスワクチンについて、国際枠組み「ＣＯＶＡＸ（コバックス）」を通じて途上国に提供する検討に入った。政府関係者が２４日明らかにした。ただ、政府はまれに血栓が生じる報告のあるアストラ製の使用を当面見合わせており、海外への提供には慎重意見もある。（2021/05/24-16:41）

The Japanese government is considering providing COVID-19 vaccines developed by AstraZeneca PLC to developing nations through COVAX, an international vaccine-sharing scheme, government sources said Monday.
   Vaccines from Pfizer Inc. and Moderna Inc. will be enough for COVID-19 vaccinations in Japan, a senior government official said.
   "Vaccines are limited in terms of quantity as well as expiration date. There are lots of countries around the world in need, so they shouldn't be wasted," the official said.
   Japan has signed deals to obtain vaccine supplies for 100 million people from Pfizer and a total of 85 million people from Moderna and AstraZeneca by the end of this year.
   By providing leftover doses to developing countries, Japan apparently wants to show its commitment to global health, sources familiar with the matter said.